A mother and baby standing by their mosquito net

The U.S. President’s Malaria Initiative (PMI) supports 24 partner countries in sub-Saharan Africa and three programs in the Greater Mekong Subregion in Southeast Asia to control and eliminate malaria. PMI delivers cost-effective, life-saving malaria interventions—such as insecticide-treated bed nets, indoor residual spraying, and essential medicines—alongside catalytic technical and operational assistance to equip and empower partner countries to end malaria. PMI is a multi-agency initiative, led by USAID and co-implemented with the U.S. Centers for Disease Control and Prevention (CDC) within the U.S. Department of Health and Human Services (HHS). PMI also has strong support from, and collaborates closely with, the Department of Defense; the National Institutes of Health; Peace Corps; and other U.S. departments, agencies, and programs. To learn more about the U.S. President’s Malaria Initiative, visit pmi.gov.


Today, PMI’s programs benefit at least 700 million people at risk of malaria. Since 2006, in countries where PMI works, global efforts have supported a 29 percent drop in malaria case rates and a 60 percent decline in malaria death rates. Child mortality has also fallen on average by 44% across PMI-supported African countries. See PMI's FY 2020 Annual Report for more information on impact and results.

Since 2005, PMI has funded nets to protect 844 million people, insecticide spraying to protect 334 million people, preventive treatment for 48 million pregnant women and 32 million children, 766 million rapid tests, 829 million fast-acting medicines, and 2 million trainings for health workers.
Graphic: Percent reductions in all-cause mortality for children under five years of age in PMI-supported African countries. See PMI's latest annual report for more details.